Chargement en cours...

Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo

We have recently demonstrated that multi-kinase inhibitors such as sorafenib and pazopanib can suppress the detection of chaperones by in situ immuno-fluorescence, which is further enhanced by phosphodiesterase 5 inhibitors. Sorafenib and pazopanib inhibited the HSP90 ATPase activity with IC50 value...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Booth, Laurence, Albers, Thomas, Roberts, Jane L., Tavallai, Mehrad, Poklepovic, Andrew, Lebedyeva, Iryna O., Dent, Paul
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5130016/
https://ncbi.nlm.nih.gov/pubmed/27259258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9752
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!